- Home
- PHAR vs FRPH Comparison
PHAR vs FRPH Comparison
Compare PHAR & FRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- FRPH
- Stock Information
- Founded
- PHAR 1988
- FRPH 1986
- Country
- PHAR Netherlands
- FRPH United States
- Employees
- PHAR N/A
- FRPH N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- FRPH Real Estate
- Sector
- PHAR Health Care
- FRPH Finance
- Exchange
- PHAR Nasdaq
- FRPH Nasdaq
- Market Cap
- PHAR 679.0M
- FRPH 576.6M
- IPO Year
- PHAR N/A
- FRPH N/A
- Fundamental
- Price
- PHAR $9.29
- FRPH $30.56
- Analyst Decision
- PHAR Strong Buy
- FRPH
- Analyst Count
- PHAR 3
- FRPH 0
- Target Price
- PHAR $27.00
- FRPH N/A
- AVG Volume (30 Days)
- PHAR 6.7K
- FRPH 24.0K
- Earning Date
- PHAR 03-13-2025
- FRPH 03-05-2025
- Dividend Yield
- PHAR N/A
- FRPH N/A
- EPS Growth
- PHAR N/A
- FRPH 45.62
- EPS
- PHAR N/A
- FRPH 0.40
- Revenue
- PHAR $285,745,000.00
- FRPH $31,414,000.00
- Revenue This Year
- PHAR $20.08
- FRPH N/A
- Revenue Next Year
- PHAR $9.22
- FRPH N/A
- P/E Ratio
- PHAR N/A
- FRPH $74.44
- Revenue Growth
- PHAR 30.64
- FRPH 4.04
- 52 Week Low
- PHAR $6.65
- FRPH $26.99
- 52 Week High
- PHAR $13.20
- FRPH $33.00
- Technical
- Relative Strength Index (RSI)
- PHAR 48.44
- FRPH 53.58
- Support Level
- PHAR $9.37
- FRPH $29.68
- Resistance Level
- PHAR $10.01
- FRPH $30.88
- Average True Range (ATR)
- PHAR 0.55
- FRPH 0.66
- MACD
- PHAR -0.13
- FRPH 0.12
- Stochastic Oscillator
- PHAR 13.82
- FRPH 86.09
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).